Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010;31(3):222-9.
doi: 10.1159/000272937. Epub 2009 Dec 31.

Effect of chronic kidney disease and comorbid conditions on health care costs: A 10-year observational study in a general population

Sebastian E Baumeister  1 , Carsten A Böger, Bernhard K Krämer, Angela Döring, Dirk Eheberg, Beate Fischer, Jürgen John, Wolfgang Koenig, Christa Meisinger
Affiliations

Effect of chronic kidney disease and comorbid conditions on health care costs: A 10-year observational study in a general population

Sebastian E Baumeister et al. Am J Nephrol. 2010.

Abstract

Background: Chronic kidney disease (CKD) is common, but the longitudinal effects of CKD and associated comorbidities on health care costs in the general population are unknown.

Methods: Population-based cohort study of 2,988 subjects in Germany, aged 25-74 years at baseline, who participated both in the baseline and 10-year follow-up examination (1994/95-2004/05). Presence of CKD was based on serum creatinine and defined as an estimated glomerular filtration rate of <60 ml/min/1.73 m(2). Self-reported health services utilization was used to estimate costs.

Results: Health care costs at baseline and follow-up were higher for subjects with CKD. Controlling for socio-economics, lifestyle factors and comorbid conditions, subjects with baseline CKD, in comparison to those without, exhibited 65% higher total costs 10 years after baseline examination, corresponding to a difference in adjusted costs of EUR 743. Incident CKD was related to 38% higher total costs. Costs for inpatient treatment and drug costs were the major costs components, while CKD revealed no effect on outpatient costs. The effect of CKD was strongly modified by angina, myocardial infarction, diabetes, and anemia.

Conclusions: The direct effect of CKD on costs is modified by comorbid conditions. Therefore, early treatment of CKD and its precipitous factors may save future health care costs.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • Derivation and Internal Validation of a Clinical Risk Prediction Tool for Hyperkalemia-Related Emergency Department Encounters Among Hemodialysis Patients.
    Ronksley PE, Wick JP, Elliott MJ, Weaver RG, Hemmelgarn BR, McRae A, James MT, Harrison TG, MacRae JM. Ronksley PE, et al. Can J Kidney Health Dis. 2020 Sep 4;7:2054358120953287. doi: 10.1177/2054358120953287. eCollection 2020. Can J Kidney Health Dis. 2020. PMID: 32953128 Free PMC article.
  • The Economic Burden of Chronic Kidney Disease in Vietnam.
    Nguyen-Thi HY, Le-Phuoc TN, Tri Phat N, Truong Van D, Le-Thi TT, Le NDT, Tran-Thi HN, Pham Dinh L. Nguyen-Thi HY, et al. Health Serv Insights. 2021 Jul 28;14:11786329211036011. doi: 10.1177/11786329211036011. eCollection 2021. Health Serv Insights. 2021. PMID: 34376990 Free PMC article.
  • Differential and shared genetic effects on kidney function between diabetic and non-diabetic individuals.
    Winkler TW, Rasheed H, Teumer A, Gorski M, Rowan BX, Stanzick KJ, Thomas LF, Tin A, Hoppmann A, Chu AY, Tayo B, Thio CHL, Cusi D, Chai JF, Sieber KB, Horn K, Li M, Scholz M, Cocca M, Wuttke M, van der Most PJ, Yang Q, Ghasemi S, Nutile T, Li Y, Pontali G, Günther F, Dehghan A, Correa A, Parsa A, Feresin A, de Vries APJ, Zonderman AB, Smith AV, Oldehinkel AJ, De Grandi A, Rosenkranz AR, Franke A, Teren A, Metspalu A, Hicks AA, Morris AP, Tönjes A, Morgan A, Podgornaia AI, Peters A, Körner A, Mahajan A, Campbell A, Freedman BI, Spedicati B, Ponte B, Schöttker B, Brumpton B, Banas B, Krämer BK, Jung B, Åsvold BO, Smith BH, Ning B, Penninx BWJH, Vanderwerff BR, Psaty BM, Kammerer CM, Langefeld CD, Hayward C, Spracklen CN, Robinson-Cohen C, Hartman CA, Lindgren CM, Wang C, Sabanayagam C, Heng CK, Lanzani C, Khor CC, Cheng CY, Fuchsberger C, Gieger C, Shaffer CM, Schulz CA, Willer CJ, Chasman DI, Gudbjartsson DF, Ruggiero D, Toniolo D, Czamara D, Porteous DJ, Waterworth DM, Mascalzoni D, Mook-Kanamori DO, Reilly DF, Daw EW, Hofer E, Boerwinkle E, Salvi E, Bottinger EP, Tai ES, Catamo E, Rizzi F, Guo F, Rivadeneira F, Guilianini F, Sveinbjornsson G, Ehret G, Waeber G, Biino G, Girotto G,… See abstract for full author list ➔ Winkler TW, et al. Commun Biol. 2022 Jun 13;5(1):580. doi: 10.1038/s42003-022-03448-z. Commun Biol. 2022. PMID: 35697829 Free PMC article.
  • UMOD as a susceptibility gene for end-stage renal disease.
    Reznichenko A, Böger CA, Snieder H, van den Born J, de Borst MH, Damman J, van Dijk MC, van Goor H, Hepkema BG, Hillebrands JL, Leuvenink HG, Niesing J, Bakker SJ, Seelen M, Navis G; REGaTTA (REnal GeneTics TrAnsplantation) Groningen group. Reznichenko A, et al. BMC Med Genet. 2012 Sep 5;13:78. doi: 10.1186/1471-2350-13-78. BMC Med Genet. 2012. PMID: 22947327 Free PMC article.
  • Is the choice of the statistical model relevant in the cost estimation of patients with chronic diseases? An empirical approach by the Piedmont Diabetes Registry.
    Pagano E, Petrelli A, Picariello R, Merletti F, Gnavi R, Bruno G. Pagano E, et al. BMC Health Serv Res. 2015 Dec 30;15:582. doi: 10.1186/s12913-015-1241-1. BMC Health Serv Res. 2015. PMID: 26714744 Free PMC article.
See all "Cited by" articles

Publication types